🚀 New investment in healthtech! Capricorn Partners, via our Capricorn Healthtech Fund II, has co-led a €20M Series C round for Endo Tools…

Capricorn Partners

8,342 followers

🚀 New investment in healthtech! Capricorn Partners, via our Capricorn Healthtech Fund II, has co-led a €20M Series C round for Endo Tools Therapeutics, together with MGFO, and joined by existing investors. 🩺 Endo Tools lets doctors treat obesity and other gastrointestinal conditions through a minimally invasive procedure instead of open surgery. Its endomina® platform attaches to a standard endoscope, letting physicians stitch and reshape tissue from inside the stomach, through the mouth, no incisions needed. 📈 The funding will fuel U.S., European and Middle East expansion, including the recently FDA-cleared endomina® EZFuse system, and the clinical evidence needed for a U.S. weight-loss indication, positioning endomina as a minimally invasive alternative to drugs like Ozempic. 💬 "The company is very well positioned to transform gastrointestinal care with minimally invasive endoscopic solutions to continue to improve patient care." - Filip Pintelon, Investment Partner at Capricorn Partners Congrats to Alexandre Chau and the entire Endo Tools team! We are excited to support your growth in the U.S. and beyond! Alexandre Chau, Marc Nolet, Matthieu Bocquet, CFA, Filip Pintelon, Katrin Geyskens, Dick Sietses, Antoine D'Hollander, Jeroen Van Iseghem, Noé Wachsmuth, Simon Wouters

💬 5↻ 4

View on LinkedIn